Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
—1,100.611,106.151,114.281,098.89——
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
—612.30612.30616.40612.30——
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
—644.73645.31649.16642.15——
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
—827.09828.05833.90827.27——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
—214.82214.82216.61212.62——
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
—3,115.173,142.773,186.203,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
—910.43915.18923.94906.03——
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
—1,474.501,480.841,491.461,475.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
—2,405.872,415.572,420.792,398.99——
2VSA:FRA
Verastem Inc
€5.12
-5.50%
(-0.30) 1D
Apr 22, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2VSA...
Open
€4.87
High
€5.12
Low
€4.87
Mkt. cap
533.21M
Avg. vol.
105.00
Volume
0.00
52-wk high
€9.00
52-wk low
€3.30
No. of employees
102
News stories
From sources across the web
Profile
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
About Verastem Inc
CEOBrian Stuglik
Employees102
Founded2010
HeadquartersNeedham, Massachusetts, United States
SectorBiotechnology
Websiteverastem.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
2.14M
11.24M
17.54M
Cost of goods sold
-
318.00K
1.67M
2.61M
Cost of revenue
-
318.00K
1.67M
2.61M
Research and development expenses
29.15M
24.79M
28.99M
31.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.02M
20.67M
21.01M
24.44M
Operating expense
44.17M
45.58M
50.29M
56.40M
Total operating expenses
44.17M
45.90M
51.96M
59.01M
Operating income
-44.17M
-43.76M
-40.72M
-41.48M
Other non operating income
-6.87M
17.22M
-58.67M
7.87M
EBT including unusual items
-52.10M
-25.93M
-98.52M
-32.92M
EBT excluding unusual items
-50.28M
-25.93M
-98.52M
-32.92M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-52.10M
-25.93M
-98.52M
-32.92M
Net profit margin
-
-1,213.57%
-876.34%
-187.72%
Earnings per share
-0.79
-0.63
-0.54
-0.46
Interest and investment income
960.00K
822.00K
1.18M
1.10M
Interest expense
-192.00K
-212.00K
-319.00K
-415.00K
Net interest expenses
768.00K
610.00K
863.00K
689.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.16M
-43.64M
-40.42M
-41.18M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer